HSK-47977

N/A

Report date: 2025/08/11 10:35:06
NME

Base Information

Drug NameHSK-47977
Drug Alias NameHSK47977HSK-47977
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionB-cell lymphoma 6 protein degraders
TargetsB-cell lymphoma 6 protein
Therapy Area/IndicationsLymphoma, Large B-Cell, DiffuseLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHaisco Pharmaceutical Group Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesHaisco Pharmaceutical Group Co Ltd
Inactive CompaniesN/A
Active IndicationsLymphoma, Large B-Cell, DiffuseLymphoma, Non-Hodgkin
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A